Author Question: Buspirone (BuSpar), a partial 5-HT1A receptor agonist, differs from benzodiazepine and barbiturate ... (Read 57 times)

ss2343

  • Hero Member
  • *****
  • Posts: 548
Buspirone (BuSpar), a partial 5-HT1A receptor agonist, differs from benzodiazepine and barbiturate anxiolytics in terms of
 
  a. dependence liability
  b. tolerance development
  c. synergistic actions with alcohol
  d. all of these

Question 2

Acamprosate (Campral) has recently been approved for use in the treatment of alcoholism. Its primary benefit appears to be
 
  a. reduction of opioid receptor activity b. reduction in desire for drinking alcohol
  c. induction of aversive effects when alcohol is consumed



Kingjoffery

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

d

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

For a complete list of videos, visit our video library